Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
0874Pharmaceuticals
HK$12.59−2.48%As of Oct 29vs prior close
- Market cap
- $352.8M
- P/E (TTM)
- 1.1×
- P/E (FY1)
- 6.7×
- From 52W high
- −34.04%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥77.9B
- Net margin
- 2.77%
- Dividend yield
- 6.85%
Nomior Score
36
Patient ValueBottom 23% of the scored universe
Growth30
Quality40
Value75
Momentum8
Resilience61
Growth
+3.13%revenue a year over 3 fiscal years
YE22 CN¥70.8BLTM CN¥77.9B
Connections
Revenue to profitYE25
4% of revenue became net profit.